Company / CapEx per Share
Vaxcyte, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.09 / $0.18
FY2021-FY2025
Trend
-45.2%
vs FY2024
Sector context
#56 of 192
Health Care
What the data says
At $0.10, Vaxcyte, Inc.'s capex per share ranks #56 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 8 years, ranging from $0.04 in FY2020 to $0.49 in FY2018.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of +20.8%.
Declined from $0.17 to $0.10 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +3.8%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
#56 of 192 in Health CareTop 29% of 192This company $0.10 Sector average $3.54
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 45.2% year-over-year.
- Ranks #56 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | -45.2% |
| FY2024 | $0.18 | +11.2% |
| FY2023 | $0.17 | +83.6% |
| FY2022 | $0.09 | -28.7% |
| FY2021 | $0.13 | +222.9% |
| FY2020 | $0.04 | -87.6% |
| FY2019 | $0.31 | -35.6% |
| FY2018 | $0.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026